nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP2C9—brain cancer	0.738	1	CbGaD
Etravirine—CYP3A4—Temozolomide—brain cancer	0.0573	0.417	CbGbCtD
Etravirine—CYP3A4—Lomustine—brain cancer	0.0488	0.354	CbGbCtD
Etravirine—ABCB1—Etoposide—brain cancer	0.0197	0.143	CbGbCtD
Etravirine—CYP3A4—Etoposide—brain cancer	0.0118	0.0857	CbGbCtD
Etravirine—Infection—Carboplatin—brain cancer	0.000906	0.00757	CcSEcCtD
Etravirine—Disorientation—Hydroxyurea—brain cancer	0.000892	0.00745	CcSEcCtD
Etravirine—Hepatic failure—Hydroxyurea—brain cancer	0.000888	0.00742	CcSEcCtD
Etravirine—Eosinophilia—Procarbazine—brain cancer	0.000882	0.00737	CcSEcCtD
Etravirine—ABCB4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000879	0.187	CbGpPWpGaD
Etravirine—Pancreatitis—Procarbazine—brain cancer	0.000874	0.0073	CcSEcCtD
Etravirine—Angina pectoris—Procarbazine—brain cancer	0.000868	0.00725	CcSEcCtD
Etravirine—Renal failure acute—Hydroxyurea—brain cancer	0.000864	0.00722	CcSEcCtD
Etravirine—Dermatitis bullous—Hydroxyurea—brain cancer	0.000835	0.00698	CcSEcCtD
Etravirine—Gynaecomastia—Carmustine—brain cancer	0.000795	0.00664	CcSEcCtD
Etravirine—Infection—Lomustine—brain cancer	0.000793	0.00663	CcSEcCtD
Etravirine—Thrombocytopenia—Lomustine—brain cancer	0.000782	0.00653	CcSEcCtD
Etravirine—Pain—Carboplatin—brain cancer	0.00078	0.00652	CcSEcCtD
Etravirine—Neuropathy peripheral—Procarbazine—brain cancer	0.000779	0.00651	CcSEcCtD
Etravirine—Stomatitis—Procarbazine—brain cancer	0.000775	0.00647	CcSEcCtD
Etravirine—Anorexia—Lomustine—brain cancer	0.000761	0.00636	CcSEcCtD
Etravirine—Diabetes mellitus—Carmustine—brain cancer	0.000742	0.0062	CcSEcCtD
Etravirine—Body temperature increased—Carboplatin—brain cancer	0.000721	0.00603	CcSEcCtD
Etravirine—Breast disorder—Hydroxyurea—brain cancer	0.000721	0.00602	CcSEcCtD
Etravirine—Inflammation—Etoposide—brain cancer	0.000708	0.00592	CcSEcCtD
Etravirine—Decreased appetite—Lomustine—brain cancer	0.000694	0.0058	CcSEcCtD
Etravirine—Hepatic failure—Temozolomide—brain cancer	0.000694	0.0058	CcSEcCtD
Etravirine—Amnesia—Carmustine—brain cancer	0.000687	0.00574	CcSEcCtD
Etravirine—Pancreatitis—Hydroxyurea—brain cancer	0.000676	0.00565	CcSEcCtD
Etravirine—Amnesia—Temozolomide—brain cancer	0.000664	0.00554	CcSEcCtD
Etravirine—Body temperature increased—Lomustine—brain cancer	0.000631	0.00527	CcSEcCtD
Etravirine—Tension—Procarbazine—brain cancer	0.000609	0.00509	CcSEcCtD
Etravirine—Nervousness—Procarbazine—brain cancer	0.000603	0.00504	CcSEcCtD
Etravirine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000603	0.00504	CcSEcCtD
Etravirine—Stomatitis—Hydroxyurea—brain cancer	0.000599	0.00501	CcSEcCtD
Etravirine—Tremor—Procarbazine—brain cancer	0.000582	0.00486	CcSEcCtD
Etravirine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000582	0.00486	CcSEcCtD
Etravirine—Anaemia—Procarbazine—brain cancer	0.000574	0.0048	CcSEcCtD
Etravirine—Dry skin—Temozolomide—brain cancer	0.000571	0.00477	CcSEcCtD
Etravirine—Breast disorder—Temozolomide—brain cancer	0.000563	0.00471	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000561	0.00469	CcSEcCtD
Etravirine—Syncope—Procarbazine—brain cancer	0.000557	0.00465	CcSEcCtD
Etravirine—Loss of consciousness—Procarbazine—brain cancer	0.000546	0.00456	CcSEcCtD
Etravirine—Abdominal distension—Temozolomide—brain cancer	0.000542	0.00453	CcSEcCtD
Etravirine—Convulsion—Procarbazine—brain cancer	0.000538	0.0045	CcSEcCtD
Etravirine—Hypertension—Procarbazine—brain cancer	0.000536	0.00448	CcSEcCtD
Etravirine—Anxiety—Procarbazine—brain cancer	0.000527	0.0044	CcSEcCtD
Etravirine—Dry mouth—Procarbazine—brain cancer	0.000517	0.00432	CcSEcCtD
Etravirine—Confusional state—Procarbazine—brain cancer	0.000511	0.00427	CcSEcCtD
Etravirine—Vomiting—Lomustine—brain cancer	0.000508	0.00424	CcSEcCtD
Etravirine—Infection—Procarbazine—brain cancer	0.000503	0.00421	CcSEcCtD
Etravirine—Hyperglycaemia—Carmustine—brain cancer	0.000503	0.0042	CcSEcCtD
Etravirine—Angiopathy—Hydroxyurea—brain cancer	0.000501	0.00418	CcSEcCtD
Etravirine—Shock—Procarbazine—brain cancer	0.000499	0.00417	CcSEcCtD
Etravirine—Thrombocytopenia—Procarbazine—brain cancer	0.000496	0.00415	CcSEcCtD
Etravirine—Hyperhidrosis—Procarbazine—brain cancer	0.00049	0.00409	CcSEcCtD
Etravirine—Renal failure—Carmustine—brain cancer	0.000489	0.00408	CcSEcCtD
Etravirine—Neuropathy peripheral—Carmustine—brain cancer	0.000487	0.00407	CcSEcCtD
Etravirine—Hyperglycaemia—Temozolomide—brain cancer	0.000486	0.00406	CcSEcCtD
Etravirine—Stomatitis—Carmustine—brain cancer	0.000485	0.00405	CcSEcCtD
Etravirine—Anorexia—Procarbazine—brain cancer	0.000483	0.00404	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000476	0.00398	CcSEcCtD
Etravirine—Nausea—Lomustine—brain cancer	0.000474	0.00396	CcSEcCtD
Etravirine—Neuropathy peripheral—Temozolomide—brain cancer	0.000471	0.00393	CcSEcCtD
Etravirine—Stomatitis—Temozolomide—brain cancer	0.000468	0.00391	CcSEcCtD
Etravirine—Insomnia—Procarbazine—brain cancer	0.000458	0.00383	CcSEcCtD
Etravirine—Paraesthesia—Procarbazine—brain cancer	0.000455	0.0038	CcSEcCtD
Etravirine—Hepatobiliary disease—Temozolomide—brain cancer	0.000454	0.0038	CcSEcCtD
Etravirine—Somnolence—Procarbazine—brain cancer	0.000451	0.00376	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000449	0.00375	CcSEcCtD
Etravirine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000446	0.00373	CcSEcCtD
Etravirine—Anaemia—Hydroxyurea—brain cancer	0.000444	0.00371	CcSEcCtD
Etravirine—Hypoaesthesia—Carmustine—brain cancer	0.000444	0.00371	CcSEcCtD
Etravirine—Decreased appetite—Procarbazine—brain cancer	0.000441	0.00368	CcSEcCtD
Etravirine—Connective tissue disorder—Carmustine—brain cancer	0.000439	0.00366	CcSEcCtD
Etravirine—Fatigue—Procarbazine—brain cancer	0.000437	0.00365	CcSEcCtD
Etravirine—Malaise—Hydroxyurea—brain cancer	0.000433	0.00362	CcSEcCtD
Etravirine—Pain—Procarbazine—brain cancer	0.000433	0.00362	CcSEcCtD
Etravirine—Constipation—Procarbazine—brain cancer	0.000433	0.00362	CcSEcCtD
Etravirine—Hepatitis—Temozolomide—brain cancer	0.000431	0.0036	CcSEcCtD
Etravirine—Hypoaesthesia—Temozolomide—brain cancer	0.000429	0.00359	CcSEcCtD
Etravirine—Urinary tract disorder—Temozolomide—brain cancer	0.000426	0.00356	CcSEcCtD
Etravirine—Bronchospasm—Etoposide—brain cancer	0.000424	0.00354	CcSEcCtD
Etravirine—Connective tissue disorder—Temozolomide—brain cancer	0.000424	0.00354	CcSEcCtD
Etravirine—Urethral disorder—Temozolomide—brain cancer	0.000423	0.00353	CcSEcCtD
Etravirine—ABCB4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00042	0.0896	CbGpPWpGaD
Etravirine—Feeling abnormal—Procarbazine—brain cancer	0.000418	0.00349	CcSEcCtD
Etravirine—Eye disorder—Carmustine—brain cancer	0.000417	0.00348	CcSEcCtD
Etravirine—Convulsion—Hydroxyurea—brain cancer	0.000416	0.00348	CcSEcCtD
Etravirine—Gastrointestinal pain—Procarbazine—brain cancer	0.000414	0.00346	CcSEcCtD
Etravirine—Erythema multiforme—Temozolomide—brain cancer	0.000408	0.00341	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000406	0.00339	CcSEcCtD
Etravirine—Discomfort—Hydroxyurea—brain cancer	0.000404	0.00338	CcSEcCtD
Etravirine—Eye disorder—Temozolomide—brain cancer	0.000403	0.00337	CcSEcCtD
Etravirine—Abdominal pain—Procarbazine—brain cancer	0.000401	0.00335	CcSEcCtD
Etravirine—Body temperature increased—Procarbazine—brain cancer	0.000401	0.00335	CcSEcCtD
Etravirine—Cardiac disorder—Temozolomide—brain cancer	0.0004	0.00334	CcSEcCtD
Etravirine—Angiopathy—Temozolomide—brain cancer	0.000391	0.00327	CcSEcCtD
Etravirine—Mental disorder—Carmustine—brain cancer	0.000391	0.00327	CcSEcCtD
Etravirine—Infection—Hydroxyurea—brain cancer	0.00039	0.00326	CcSEcCtD
Etravirine—Immune system disorder—Temozolomide—brain cancer	0.00039	0.00325	CcSEcCtD
Etravirine—Mediastinal disorder—Temozolomide—brain cancer	0.000389	0.00325	CcSEcCtD
Etravirine—Malnutrition—Carmustine—brain cancer	0.000388	0.00325	CcSEcCtD
Etravirine—Nervous system disorder—Hydroxyurea—brain cancer	0.000385	0.00321	CcSEcCtD
Etravirine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000384	0.00321	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000381	0.00318	CcSEcCtD
Etravirine—Skin disorder—Hydroxyurea—brain cancer	0.000381	0.00318	CcSEcCtD
Etravirine—Acute coronary syndrome—Etoposide—brain cancer	0.000379	0.00317	CcSEcCtD
Etravirine—Renal failure—Etoposide—brain cancer	0.000378	0.00316	CcSEcCtD
Etravirine—Mental disorder—Temozolomide—brain cancer	0.000378	0.00316	CcSEcCtD
Etravirine—Neuropathy peripheral—Etoposide—brain cancer	0.000377	0.00315	CcSEcCtD
Etravirine—Myocardial infarction—Etoposide—brain cancer	0.000377	0.00315	CcSEcCtD
Etravirine—Malnutrition—Temozolomide—brain cancer	0.000375	0.00314	CcSEcCtD
Etravirine—Stomatitis—Etoposide—brain cancer	0.000375	0.00313	CcSEcCtD
Etravirine—Anorexia—Hydroxyurea—brain cancer	0.000374	0.00312	CcSEcCtD
Etravirine—Hypersensitivity—Procarbazine—brain cancer	0.000373	0.00312	CcSEcCtD
Etravirine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000369	0.0786	CbGpPWpGaD
Etravirine—Vision blurred—Carmustine—brain cancer	0.000366	0.00306	CcSEcCtD
Etravirine—Tremor—Carmustine—brain cancer	0.000364	0.00304	CcSEcCtD
Etravirine—Asthenia—Procarbazine—brain cancer	0.000364	0.00304	CcSEcCtD
Etravirine—Hepatobiliary disease—Etoposide—brain cancer	0.000364	0.00304	CcSEcCtD
Etravirine—Anaemia—Carmustine—brain cancer	0.000359	0.003	CcSEcCtD
Etravirine—Vision blurred—Temozolomide—brain cancer	0.000354	0.00296	CcSEcCtD
Etravirine—Tremor—Temozolomide—brain cancer	0.000352	0.00294	CcSEcCtD
Etravirine—Somnolence—Hydroxyurea—brain cancer	0.000349	0.00291	CcSEcCtD
Etravirine—Ill-defined disorder—Temozolomide—brain cancer	0.000348	0.00291	CcSEcCtD
Etravirine—Anaemia—Temozolomide—brain cancer	0.000347	0.0029	CcSEcCtD
Etravirine—Diarrhoea—Procarbazine—brain cancer	0.000347	0.0029	CcSEcCtD
Etravirine—Hypoaesthesia—Etoposide—brain cancer	0.000343	0.00287	CcSEcCtD
Etravirine—Angioedema—Temozolomide—brain cancer	0.000343	0.00287	CcSEcCtD
Etravirine—Decreased appetite—Hydroxyurea—brain cancer	0.000341	0.00285	CcSEcCtD
Etravirine—Urinary tract disorder—Etoposide—brain cancer	0.000341	0.00285	CcSEcCtD
Etravirine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000339	0.00283	CcSEcCtD
Etravirine—Malaise—Temozolomide—brain cancer	0.000339	0.00283	CcSEcCtD
Etravirine—Urethral disorder—Etoposide—brain cancer	0.000338	0.00283	CcSEcCtD
Etravirine—Fatigue—Hydroxyurea—brain cancer	0.000338	0.00283	CcSEcCtD
Etravirine—Vertigo—Temozolomide—brain cancer	0.000337	0.00282	CcSEcCtD
Etravirine—Convulsion—Carmustine—brain cancer	0.000337	0.00281	CcSEcCtD
Etravirine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000336	0.0715	CbGpPWpGaD
Etravirine—Hypertension—Carmustine—brain cancer	0.000335	0.0028	CcSEcCtD
Etravirine—Pain—Hydroxyurea—brain cancer	0.000335	0.0028	CcSEcCtD
Etravirine—Constipation—Hydroxyurea—brain cancer	0.000335	0.0028	CcSEcCtD
Etravirine—Dizziness—Procarbazine—brain cancer	0.000335	0.0028	CcSEcCtD
Etravirine—Anxiety—Carmustine—brain cancer	0.00033	0.00275	CcSEcCtD
Etravirine—Erythema multiforme—Etoposide—brain cancer	0.000326	0.00273	CcSEcCtD
Etravirine—Convulsion—Temozolomide—brain cancer	0.000325	0.00272	CcSEcCtD
Etravirine—Hypertension—Temozolomide—brain cancer	0.000324	0.00271	CcSEcCtD
Etravirine—Feeling abnormal—Hydroxyurea—brain cancer	0.000323	0.0027	CcSEcCtD
Etravirine—Eye disorder—Etoposide—brain cancer	0.000323	0.00269	CcSEcCtD
Etravirine—Vomiting—Procarbazine—brain cancer	0.000322	0.00269	CcSEcCtD
Etravirine—Cardiac disorder—Etoposide—brain cancer	0.00032	0.00268	CcSEcCtD
Etravirine—Confusional state—Carmustine—brain cancer	0.00032	0.00267	CcSEcCtD
Etravirine—Rash—Procarbazine—brain cancer	0.00032	0.00267	CcSEcCtD
Etravirine—Dermatitis—Procarbazine—brain cancer	0.000319	0.00267	CcSEcCtD
Etravirine—Anxiety—Temozolomide—brain cancer	0.000319	0.00266	CcSEcCtD
Etravirine—Headache—Procarbazine—brain cancer	0.000317	0.00265	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000317	0.00265	CcSEcCtD
Etravirine—Discomfort—Temozolomide—brain cancer	0.000316	0.00264	CcSEcCtD
Etravirine—Infection—Carmustine—brain cancer	0.000315	0.00263	CcSEcCtD
Etravirine—Angiopathy—Etoposide—brain cancer	0.000313	0.00262	CcSEcCtD
Etravirine—Dry mouth—Temozolomide—brain cancer	0.000313	0.00261	CcSEcCtD
Etravirine—Immune system disorder—Etoposide—brain cancer	0.000312	0.0026	CcSEcCtD
Etravirine—Mediastinal disorder—Etoposide—brain cancer	0.000311	0.0026	CcSEcCtD
Etravirine—Thrombocytopenia—Carmustine—brain cancer	0.00031	0.00259	CcSEcCtD
Etravirine—Body temperature increased—Hydroxyurea—brain cancer	0.00031	0.00259	CcSEcCtD
Etravirine—Confusional state—Temozolomide—brain cancer	0.000309	0.00258	CcSEcCtD
Etravirine—Infection—Temozolomide—brain cancer	0.000304	0.00254	CcSEcCtD
Etravirine—Anorexia—Carmustine—brain cancer	0.000302	0.00253	CcSEcCtD
Etravirine—Nausea—Procarbazine—brain cancer	0.000301	0.00252	CcSEcCtD
Etravirine—Nervous system disorder—Temozolomide—brain cancer	0.0003	0.00251	CcSEcCtD
Etravirine—Thrombocytopenia—Temozolomide—brain cancer	0.0003	0.00251	CcSEcCtD
Etravirine—Skin disorder—Temozolomide—brain cancer	0.000298	0.00249	CcSEcCtD
Etravirine—Hyperhidrosis—Temozolomide—brain cancer	0.000296	0.00247	CcSEcCtD
Etravirine—Anorexia—Temozolomide—brain cancer	0.000292	0.00244	CcSEcCtD
Etravirine—Hypersensitivity—Hydroxyurea—brain cancer	0.000289	0.00241	CcSEcCtD
Etravirine—Insomnia—Carmustine—brain cancer	0.000287	0.0024	CcSEcCtD
Etravirine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000286	0.0609	CbGpPWpGaD
Etravirine—Paraesthesia—Carmustine—brain cancer	0.000285	0.00238	CcSEcCtD
Etravirine—Somnolence—Carmustine—brain cancer	0.000282	0.00236	CcSEcCtD
Etravirine—Asthenia—Hydroxyurea—brain cancer	0.000281	0.00235	CcSEcCtD
Etravirine—Ill-defined disorder—Etoposide—brain cancer	0.000279	0.00233	CcSEcCtD
Etravirine—Anaemia—Etoposide—brain cancer	0.000278	0.00232	CcSEcCtD
Etravirine—Insomnia—Temozolomide—brain cancer	0.000277	0.00232	CcSEcCtD
Etravirine—Decreased appetite—Carmustine—brain cancer	0.000276	0.0023	CcSEcCtD
Etravirine—Paraesthesia—Temozolomide—brain cancer	0.000275	0.0023	CcSEcCtD
Etravirine—Gastrointestinal disorder—Carmustine—brain cancer	0.000274	0.00229	CcSEcCtD
Etravirine—Somnolence—Temozolomide—brain cancer	0.000272	0.00228	CcSEcCtD
Etravirine—Pain—Carmustine—brain cancer	0.000271	0.00227	CcSEcCtD
Etravirine—Constipation—Carmustine—brain cancer	0.000271	0.00227	CcSEcCtD
Etravirine—Malaise—Etoposide—brain cancer	0.000271	0.00226	CcSEcCtD
Etravirine—Vertigo—Etoposide—brain cancer	0.00027	0.00226	CcSEcCtD
Etravirine—Diarrhoea—Hydroxyurea—brain cancer	0.000268	0.00224	CcSEcCtD
Etravirine—Decreased appetite—Temozolomide—brain cancer	0.000266	0.00223	CcSEcCtD
Etravirine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000265	0.00221	CcSEcCtD
Etravirine—Fatigue—Temozolomide—brain cancer	0.000264	0.00221	CcSEcCtD
Etravirine—Loss of consciousness—Etoposide—brain cancer	0.000264	0.00221	CcSEcCtD
Etravirine—Pain—Temozolomide—brain cancer	0.000262	0.00219	CcSEcCtD
Etravirine—Constipation—Temozolomide—brain cancer	0.000262	0.00219	CcSEcCtD
Etravirine—Feeling abnormal—Carmustine—brain cancer	0.000261	0.00218	CcSEcCtD
Etravirine—Convulsion—Etoposide—brain cancer	0.00026	0.00217	CcSEcCtD
Etravirine—Hypertension—Etoposide—brain cancer	0.000259	0.00217	CcSEcCtD
Etravirine—Dizziness—Hydroxyurea—brain cancer	0.000259	0.00217	CcSEcCtD
Etravirine—Gastrointestinal pain—Carmustine—brain cancer	0.000259	0.00217	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000254	0.00212	CcSEcCtD
Etravirine—Discomfort—Etoposide—brain cancer	0.000253	0.00211	CcSEcCtD
Etravirine—Feeling abnormal—Temozolomide—brain cancer	0.000252	0.00211	CcSEcCtD
Etravirine—Body temperature increased—Carmustine—brain cancer	0.000251	0.00209	CcSEcCtD
Etravirine—Abdominal pain—Carmustine—brain cancer	0.000251	0.00209	CcSEcCtD
Etravirine—Gastrointestinal pain—Temozolomide—brain cancer	0.000251	0.00209	CcSEcCtD
Etravirine—Vomiting—Hydroxyurea—brain cancer	0.000249	0.00208	CcSEcCtD
Etravirine—Rash—Hydroxyurea—brain cancer	0.000247	0.00207	CcSEcCtD
Etravirine—Confusional state—Etoposide—brain cancer	0.000247	0.00207	CcSEcCtD
Etravirine—Dermatitis—Hydroxyurea—brain cancer	0.000247	0.00206	CcSEcCtD
Etravirine—Headache—Hydroxyurea—brain cancer	0.000246	0.00205	CcSEcCtD
Etravirine—Infection—Etoposide—brain cancer	0.000244	0.00204	CcSEcCtD
Etravirine—Abdominal pain—Temozolomide—brain cancer	0.000242	0.00202	CcSEcCtD
Etravirine—Body temperature increased—Temozolomide—brain cancer	0.000242	0.00202	CcSEcCtD
Etravirine—Thrombocytopenia—Etoposide—brain cancer	0.00024	0.00201	CcSEcCtD
Etravirine—Skin disorder—Etoposide—brain cancer	0.000238	0.00199	CcSEcCtD
Etravirine—Hyperhidrosis—Etoposide—brain cancer	0.000237	0.00198	CcSEcCtD
Etravirine—Anorexia—Etoposide—brain cancer	0.000234	0.00195	CcSEcCtD
Etravirine—Hypersensitivity—Carmustine—brain cancer	0.000234	0.00195	CcSEcCtD
Etravirine—Nausea—Hydroxyurea—brain cancer	0.000233	0.00195	CcSEcCtD
Etravirine—Asthenia—Carmustine—brain cancer	0.000227	0.0019	CcSEcCtD
Etravirine—Hypersensitivity—Temozolomide—brain cancer	0.000226	0.00189	CcSEcCtD
Etravirine—Paraesthesia—Etoposide—brain cancer	0.00022	0.00184	CcSEcCtD
Etravirine—Asthenia—Temozolomide—brain cancer	0.00022	0.00184	CcSEcCtD
Etravirine—Somnolence—Etoposide—brain cancer	0.000218	0.00182	CcSEcCtD
Etravirine—Diarrhoea—Carmustine—brain cancer	0.000217	0.00181	CcSEcCtD
Etravirine—Decreased appetite—Etoposide—brain cancer	0.000213	0.00178	CcSEcCtD
Etravirine—Gastrointestinal disorder—Etoposide—brain cancer	0.000212	0.00177	CcSEcCtD
Etravirine—Fatigue—Etoposide—brain cancer	0.000211	0.00177	CcSEcCtD
Etravirine—Dizziness—Carmustine—brain cancer	0.00021	0.00175	CcSEcCtD
Etravirine—Constipation—Etoposide—brain cancer	0.00021	0.00175	CcSEcCtD
Etravirine—Pain—Etoposide—brain cancer	0.00021	0.00175	CcSEcCtD
Etravirine—Diarrhoea—Temozolomide—brain cancer	0.00021	0.00175	CcSEcCtD
Etravirine—Dizziness—Temozolomide—brain cancer	0.000203	0.00169	CcSEcCtD
Etravirine—Feeling abnormal—Etoposide—brain cancer	0.000202	0.00169	CcSEcCtD
Etravirine—Vomiting—Carmustine—brain cancer	0.000202	0.00168	CcSEcCtD
Etravirine—Gastrointestinal pain—Etoposide—brain cancer	0.0002	0.00168	CcSEcCtD
Etravirine—Rash—Carmustine—brain cancer	0.0002	0.00167	CcSEcCtD
Etravirine—Dermatitis—Carmustine—brain cancer	0.0002	0.00167	CcSEcCtD
Etravirine—Headache—Carmustine—brain cancer	0.000199	0.00166	CcSEcCtD
Etravirine—Vomiting—Temozolomide—brain cancer	0.000195	0.00163	CcSEcCtD
Etravirine—Abdominal pain—Etoposide—brain cancer	0.000194	0.00162	CcSEcCtD
Etravirine—Body temperature increased—Etoposide—brain cancer	0.000194	0.00162	CcSEcCtD
Etravirine—Rash—Temozolomide—brain cancer	0.000193	0.00161	CcSEcCtD
Etravirine—Dermatitis—Temozolomide—brain cancer	0.000193	0.00161	CcSEcCtD
Etravirine—Headache—Temozolomide—brain cancer	0.000192	0.0016	CcSEcCtD
Etravirine—Nausea—Carmustine—brain cancer	0.000188	0.00157	CcSEcCtD
Etravirine—Nausea—Temozolomide—brain cancer	0.000182	0.00152	CcSEcCtD
Etravirine—Hypersensitivity—Etoposide—brain cancer	0.000181	0.00151	CcSEcCtD
Etravirine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000177	0.0378	CbGpPWpGaD
Etravirine—Asthenia—Etoposide—brain cancer	0.000176	0.00147	CcSEcCtD
Etravirine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00017	0.0363	CbGpPWpGaD
Etravirine—Diarrhoea—Etoposide—brain cancer	0.000168	0.0014	CcSEcCtD
Etravirine—Dizziness—Etoposide—brain cancer	0.000162	0.00135	CcSEcCtD
Etravirine—Vomiting—Etoposide—brain cancer	0.000156	0.0013	CcSEcCtD
Etravirine—Rash—Etoposide—brain cancer	0.000155	0.00129	CcSEcCtD
Etravirine—Dermatitis—Etoposide—brain cancer	0.000154	0.00129	CcSEcCtD
Etravirine—Headache—Etoposide—brain cancer	0.000154	0.00128	CcSEcCtD
Etravirine—Nausea—Etoposide—brain cancer	0.000146	0.00122	CcSEcCtD
Etravirine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000122	0.0259	CbGpPWpGaD
Etravirine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000119	0.0253	CbGpPWpGaD
Etravirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000113	0.0241	CbGpPWpGaD
Etravirine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000107	0.0227	CbGpPWpGaD
Etravirine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000102	0.0218	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.23e-05	0.0197	CbGpPWpGaD
Etravirine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	8.51e-05	0.0181	CbGpPWpGaD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	7.36e-05	0.0157	CbGpPWpGaD
Etravirine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	7.31e-05	0.0156	CbGpPWpGaD
Etravirine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	7.26e-05	0.0155	CbGpPWpGaD
Etravirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	6.97e-05	0.0149	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.75e-05	0.0144	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	5.96e-05	0.0127	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	4.63e-05	0.00986	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	4.42e-05	0.00943	CbGpPWpGaD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	4.36e-05	0.0093	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	4.12e-05	0.00879	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP2C9—brain cancer	4.11e-05	0.00876	CbGpPWpGaD
Etravirine—CYP3A4—Irinotecan Pathway—APC—brain cancer	3.76e-05	0.00801	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	3.59e-05	0.00764	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—BSG—brain cancer	3.49e-05	0.00745	CbGpPWpGaD
Etravirine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	3.33e-05	0.0071	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	3.17e-05	0.00675	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	3.12e-05	0.00666	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—IDH1—brain cancer	3e-05	0.0064	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	2.89e-05	0.00615	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.45e-05	0.00521	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ENO2—brain cancer	2.37e-05	0.00506	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	1.97e-05	0.0042	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	1.9e-05	0.00406	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	1.88e-05	0.004	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	1.64e-05	0.0035	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	1.56e-05	0.00332	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	1.36e-05	0.0029	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	1.31e-05	0.0028	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	1.23e-05	0.00263	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.22e-05	0.00259	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CG—brain cancer	1.09e-05	0.00232	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	1.08e-05	0.0023	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL2—brain cancer	1.07e-05	0.00229	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	1.06e-05	0.00226	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	1.05e-05	0.00225	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.05e-05	0.00223	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	9.72e-06	0.00207	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	9.26e-06	0.00197	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—VEGFA—brain cancer	9.13e-06	0.00195	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.89e-06	0.0019	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.11e-06	0.00173	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	8.01e-06	0.00171	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	7.54e-06	0.00161	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	6.29e-06	0.00134	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.85e-06	0.00125	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2C9—brain cancer	5.42e-06	0.00115	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2C9—brain cancer	5.29e-06	0.00113	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.17e-06	0.0011	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.12e-06	0.00109	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BSG—brain cancer	4.61e-06	0.000982	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.51e-06	0.000961	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BSG—brain cancer	4.5e-06	0.000958	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BSG—brain cancer	4.2e-06	0.000895	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.15e-06	0.000884	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.06e-06	0.000865	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—IDH1—brain cancer	3.96e-06	0.000844	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—IDH1—brain cancer	3.87e-06	0.000824	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—IDH1—brain cancer	3.61e-06	0.00077	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.41e-06	0.000726	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2C9—brain cancer	3.26e-06	0.000694	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.22e-06	0.000687	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ENO2—brain cancer	3.13e-06	0.000667	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ENO2—brain cancer	3.06e-06	0.000651	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.94e-06	0.000627	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ENO2—brain cancer	2.85e-06	0.000609	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BSG—brain cancer	2.77e-06	0.00059	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—IDH1—brain cancer	2.38e-06	0.000508	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ENO2—brain cancer	1.88e-06	0.000401	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CG—brain cancer	1.44e-06	0.000306	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CG—brain cancer	1.4e-06	0.000299	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CG—brain cancer	1.31e-06	0.000279	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CG—brain cancer	8.64e-07	0.000184	CbGpPWpGaD
